These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 8397453

  • 1. Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (Macaca fascicularis).
    Hummler H, Richter WF, Hendrickx AG.
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):34-45. PubMed ID: 8397453
    [Abstract] [Full Text] [Related]

  • 2. Developmental toxicity of temafloxacin hydrochloride in the long-tailed macaque (Macaca fascicularis).
    Tarantal AF, Lehrer SB, Lasley BL, Hendrickx AG.
    Teratology; 1990 Sep; 42(3):233-42. PubMed ID: 2274889
    [Abstract] [Full Text] [Related]

  • 3. Embryotoxicity studies of norfloxacin in cynomolgus monkeys. II. Role of progesterone.
    Cukierski MA, Hendrickx AG, Prahalada S, Tarantal AF, Hess DL, Lasley BL, Peter CP, Tarara R, Robertson RT.
    Teratology; 1992 Nov; 46(5):429-38. PubMed ID: 1462247
    [Abstract] [Full Text] [Related]

  • 4. Embryotoxicity studies of norfloxacin in cynomolgus monkeys: I. Teratology studies and norfloxacin plasma concentration in pregnant and nonpregnant monkeys.
    Cukierski MA, Prahalada S, Zacchei AG, Peter CP, Rodgers JD, Hess DL, Cukierski MJ, Tarantal AF, Nyland T, Robertson RT.
    Teratology; 1989 Jan; 39(1):39-52. PubMed ID: 2718139
    [Abstract] [Full Text] [Related]

  • 5. Ciprofloxacin and norfloxacin pharmacokinetics and prostatic fluid penetration in dogs after multiple oral dosing.
    Albarellos GA, Montoya L, Waxman S, Kreil V, Ambros LA, Hallu R, Rebuelto M.
    Vet J; 2006 Sep; 172(2):334-9. PubMed ID: 15994101
    [Abstract] [Full Text] [Related]

  • 6. Kinetic disposition of temafloxacin and ciprofloxacin in a murine model of pneumococcal pneumonia. Relevance for drug efficacy.
    Vallée E, Azoulay-Dupuis E, Bauchet J, Pocidalo JJ.
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1203-8. PubMed ID: 1326627
    [Abstract] [Full Text] [Related]

  • 7. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D.
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [Abstract] [Full Text] [Related]

  • 8. Fluorometric and high-performance liquid chromatographic measurement of quinolone uptake by human neutrophils.
    Pascual A, García I, Conejo MC, Perea EJ.
    Eur J Clin Microbiol Infect Dis; 1991 Nov; 10(11):969-71. PubMed ID: 1665416
    [Abstract] [Full Text] [Related]

  • 9. Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg.
    Boothe DM, Boeckh A, Boothe HW, Wilkie S, Jones S.
    Vet Ther; 2002 Nov; 3(4):409-19. PubMed ID: 12584678
    [Abstract] [Full Text] [Related]

  • 10. Teratogenicity of all-trans retinoic acid during early embryonic development in the cynomolgus monkey (Macaca fascicularis).
    Hendrickx AG, Hummler H.
    Teratology; 1992 Jan; 45(1):65-74. PubMed ID: 1731397
    [Abstract] [Full Text] [Related]

  • 11. Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones.
    Blum RA.
    Am J Med; 1992 Apr 06; 92(4A):18S-21S. PubMed ID: 1316065
    [Abstract] [Full Text] [Related]

  • 12. Penetration of enrofloxacin and ciprofloxacin into breast milk, and pharmacokinetics of the drugs in lactating rabbits and neonatal offspring.
    Aramayona JJ, Mora J, Fraile LJ, García MA, Abadía AR, Bregante MA.
    Am J Vet Res; 1996 Apr 06; 57(4):547-53. PubMed ID: 8712523
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.
    Mengozzi G, Intorre L, Bertini S, Soldani G.
    Am J Vet Res; 1996 Jul 06; 57(7):1040-3. PubMed ID: 8807018
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.
    Anadón A, Martínez-Larrañaga MR, Díaz MJ, Fernández-Cruz ML, Martínez MA, Frejo MT, Martínez M, Iturbe J, Tafur M.
    Am J Vet Res; 1999 Nov 06; 60(11):1377-82. PubMed ID: 10566812
    [Abstract] [Full Text] [Related]

  • 15. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections.
    Frankenschmidt A, Naber KG, Bischoff W, Kullmann K.
    J Urol; 1997 Oct 06; 158(4):1494-9. PubMed ID: 9302150
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intestinal elimination of sparfloxacin, fleroxacin, and ciprofloxacin in rats.
    Rubinstein E, Dautrey S, Farinoti R, St Julien L, Ramon J, Carbon C.
    Antimicrob Agents Chemother; 1995 Jan 06; 39(1):99-102. PubMed ID: 7695338
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.